Stockscreener 앱 받기
24.00
2.10%
-0.315
전일 마감가:
$24.31
열려 있는:
$24.31
하루 거래량:
22,585
Relative Volume:
0.06
시가총액:
$914.55M
수익:
$95.07M
순이익/손실:
$-60.37M
주가수익비율:
-14.73
EPS:
-1.6291
순현금흐름:
$-50.92M
1주 성능:
+2.01%
1개월 성능:
+33.04%
6개월 성능:
+17.71%
1년 성능:
+103.77%
1일 변동 폭
$23.80
$24.31
1주일 범위
$22.98
$25.33
52주 변동 폭
$10.85
$25.33
Ceribell Inc Stock (CBLL) Company Profile
명칭
Ceribell Inc
전화
(800) 436-0826
주소
360 N. PASTORIA AVENUE, SUNNYVALE
Compare CBLL vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
23.83 | 955.23M | 95.07M | -60.37M | -50.92M | -1.6291 |
ABT
Abbott Laboratories
|
114.68 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.90 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.28 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.62 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.50 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-21 | 개시 | Raymond James | Strong Buy |
| 2025-06-24 | 개시 | BTIG Research | Buy |
| 2025-04-04 | 개시 | Ladenburg Thalmann | Buy |
| 2024-11-05 | 개시 | BofA Securities | Buy |
| 2024-11-05 | 개시 | Canaccord Genuity | Buy |
| 2024-11-05 | 개시 | JP Morgan | Overweight |
| 2024-11-05 | 개시 | TD Cowen | Buy |
| 2024-11-05 | 개시 | William Blair | Outperform |
모두보기
Ceribell Inc 주식(CBLL)의 최신 뉴스
Ceribell CFO Scott Blumberg sells over $863k in company stock - Investing.com Nigeria
Ceribell CEO sells $841,292 in company stock - Investing.com
Ceribell (CBLL) updates insider trading report - Stock Titan
Ceribell (CBLL) CFO sells 34,502 shares near $25 under 10b5-1 plan - Stock Titan
Scott Blumberg Sells 33,512 Shares of CeriBell (NASDAQ:CBLL) Stock - MarketBeat
Insider Selling: CeriBell (NASDAQ:CBLL) CFO Sells $24,750.00 in Stock - MarketBeat
Ceribell CEO sells $841,292 in company stock By Investing.com - Investing.com Canada
CeriBell (NASDAQ:CBLL) CEO Sells 2,199 Shares - MarketBeat
CeriBell (NASDAQ:CBLL) CEO Xingjuan Chao Sells 31,415 Shares of Stock - MarketBeat
Ceribell (CBLL) CEO sells 33,614 shares in 10b5-1 trades - Stock Titan
CeriBell (CBLL) Results Versus Estimates: EPS Falls Short of Its Estimate in the Current Update; Price Move: The Stock Records a 0.78% Decrease in the Latest ReadingEarnings Stability Report - Vinanet
BTIG Maintains Ceribell(CBLL.US) With Buy Rating, Raises Target Price to $30 - Moomoo
BTIG raises Ceribell stock price target to $30 on growth outlook - Investing.com South Africa
TimesSquare Capital Management LLC Makes New $15.18 Million Investment in CeriBell, Inc. $CBLL - MarketBeat
Ceribell (CBLL) CEO exercises 33K stock options in August - Stock Titan
CeriBell (NASDAQ:CBLL) Sets New 52-Week HighStill a Buy? - MarketBeat
Don't Ignore The Insider Selling In CeriBell - simplywall.st
Ceribell director Joseph Taylor sells $306,423 in company stock By Investing.com - Investing.com Nigeria
Ceribell Director Joseph Michael Taylor Sells 13,095 Shares at $23.4 Each - Kalkine Media
Ceribell director Joseph Taylor sells $306,423 in company stock - Investing.com
CeriBell (NASDAQ:CBLL) Director Joseph Michael Taylor Sells 13,095 Shares - MarketBeat
CeriBell, Inc.: Fundamental Analysis and Financial Ratings | W3H | US15678C1027 - marketscreener.com
Ceribell (CBLL) director sells 13,095 shares of common stock at $23.40 - Stock Titan
CeriBell (NASDAQ:CBLL) Trading Up 9.7%Here's Why - MarketBeat
Analysts’ Opinions Are Mixed on These NA Stocks: Cardinal Infrastructure Group, Inc. (CDNL), Arcturus Therapeutics (ARCT) and Ceribell, Inc. (CBLL) - The Globe and Mail
Ceribell Wins FDA Nod for AI Tools on Its Neurology Portal - Medical Product Outsourcing
CeriBell at canaccord growth conference: sees long runway ahead By Investing.com - Investing.com Canada
CeriBell Expands EEG Platform Beyond Seizures With Delirium, Pediatric Push - MarketBeat
CeriBell at canaccord growth conference: sees long runway ahead - Investing.com
CeriBell Inc (CBLL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CeriBell revenue up 33% to USD 28.1M Q2 2026 - Medical Buyer
Canaccord raises Ceribell stock price target on strong Q2 results By Investing.com - Investing.com UK
Analysts Offer Insights on NA Companies: Ceribell, Inc. (CBLL) and Janus Living, Inc. Class A (JAN) - The Globe and Mail
CeriBell (NASDAQ:CBLL) Sees Large Volume IncreaseHere's What Happened - MarketBeat
BofA Securities Maintains Ceribell(CBLL.US) With Buy Rating - Moomoo
CeriBell (NASDAQ:CBLL) Receives "Buy" Rating from BTIG Research - MarketBeat
Canaccord raises Ceribell stock price target on strong Q2 results - Investing.com
CeriBell, Inc. Stock 12‑Month Price Target Raised to $27, Implies 40% Upside - TradingView
CeriBell Lifts 2026 Revenue Forecast on AI EEG Growth, Reports Wider Quarterly Loss - TechStock²
CBLL : Ceribell, Inc. Key Company Details - Zacks Investment Research
CeriBell, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
CeriBell Q2 revenue rises 33%, raises FY26 guidance to $114M-$117M - scanx.trade
Here's What Key Metrics Tell Us About CeriBell, Inc. (CBLL) Q2 Earnings - Yahoo Finance
CeriBell (NASDAQ:CBLL) Releases Earnings Results - MarketBeat
CeriBell Q2 Earnings Call Highlights - MarketBeat
Ceribell forecasts FY 2026 revenue of $114 million-$117 million - Bitget
CeriBell, Inc. (CBLL) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings call transcript: Ceribell tops revenue growth in Q2 2026, shares rise - Investing.com Nigeria
CeriBell, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
CeriBell Reports Q2 2026 Financial Results in 8-K Filing - Kalkine Media
Ceribell (Nasdaq: CBLL) grows Q2 2026 revenue 33% but posts larger loss - Stock Titan
Ceribell Inc (CBLL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.59%
0.75%
자본화:
|
볼륨(24시간):